Chinook Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch KDNY and buy or sell other stocks, ETFs, and their options commission-free!About KDNY
Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA.
CEOEric L. Dobmeier
CEOEric L. Dobmeier
Employees—
Employees—
HeadquartersSeattle, Washington
HeadquartersSeattle, Washington
Founded2000
Founded2000
Employees—
Employees—
KDNY Key Statistics
Market cap2.90B
Market cap2.90B
Price-Earnings ratio-11.49
Price-Earnings ratio-11.49
Dividend yield—
Dividend yield—
Average volume1.98M
Average volume1.98M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$40.51
52 Week high$40.51
52 Week low$18.34
52 Week low$18.34
Stock Snapshot
As of today, Chinook Therapeutics(KDNY) shares are valued at $40.39. The company's market cap stands at 2.9B, with a P/E ratio of -11.49.
Chinook Therapeutics(KDNY) stock opened on 2026-01-04 at —. The price climbed to — and dipped to —.
The Chinook Therapeutics(KDNY)'s current trading volume is 0, compared to an average daily volume of 1.98M.
In the last year, Chinook Therapeutics(KDNY) shares hit a 52-week high of $40.51 and a 52-week low of $18.34.
In the last year, Chinook Therapeutics(KDNY) shares hit a 52-week high of $40.51 and a 52-week low of $18.34.
People also own
Based on the portfolios of people who own KDNY. This list is generated using Robinhood data, and it’s not a recommendation.